Polygenic risk scores (PRSs) of common genetic variants have shown promise in prostate
cancer risk stratification, but their validity across populations has yet to be confirmed. We …

The transferability and clinical value of genetic risk scores (GRSs) across populations remain
limited due to an imbalance in genetic studies across ancestrally diverse populations. Here …

… Author contributions: Anna Plym had full access to all the data in the study and takes …
Financial disclosures: Anna Plym certifies that all conflicts of interest, including specific financial …

Background Malignant melanoma (MM) is one of the most common malignancies in young
women. It remains debated whether a MM diagnosed during pregnancy or lactation has a …

Context Prostate cancer (PCa) is a leading cause of death and partially heritable. Genetic
risk prediction might be useful for strategies to reduce PCa mortality through early detection …

Background: We recently developed a multi-ancestry polygenic risk score (PRS) that
effectively stratifies prostate cancer risk across populations. In this study, we validated the …

Introduction The impact of prediabetes and diabetes on stroke and the development of
dementia after a stroke remain unclear. Methods A total of 2655 dementia‐free participants (…

Background: The ability to account for comorbidity when estimating survival in a population
diagnosed with cancer could be improved by using a drug comorbidity index based on filled …

Purpose: Family history of prostate cancer is one of the few universally accepted risk factors
for prostate cancer. How much an assessment of inherited polygenic risk for prostate cancer …

Background Altered DNA damage response (DDR) has emerged as an important mechanism
for the development of aggressive prostate cancer among men of European ancestry but …